ISSN 2456-0235

International Journal of Modern Science and Technology

INDEXED IN 

International Journal of Modern Science and Technology 2024;9(1):1-13.                Full Paper (PDF)
Comprehensive review on occurrence and risk of infectious diseases and implications in health of migrants in Latin America during the prevalence of COVID -19 pandemic

​K. Rajamohammed Khader¹, S. Ivo Romauld², Marimuthu Govindarajan³,⁴, Gurunathan Baskar¹*
¹Department of Biotechnology, St. Joseph’s College of Engineering, Chennai. India.
²Department of Bioengineering, School of Engineering, Vels Institute of Science Technology and Advanced Studies (VISTAS), Chennai. India.
³Unit of Mycology and Parasitology, Department of Zoology, Annamalai University, Annamalainagar-608 002, Tamil Nadu, India.
⁴Unit of Natural Products and Nanotechnology, Department of Zoology, Government College for Women (Autonomous), Kumbakonam 612 001, Tamil Nadu, India.
*Corresponding author’s e-mail: basg2004@gmail.com

​​Abstract
In recent years, there has been a significant influx of migrants in Latin America, with a particular focus on international migration. The migrants increased the danger of contracting infectious and tropical diseases like malaria, arboviral illnesses, HIV, tuberculosis, and negative health effects. Among freshly arriving migrants, hypothermia, cardiovascular events, pregnancy related difficulties, and hypertension are the most common health issues. Particularly in Latin America and the Caribbean, the legal landscape changed as a result of Argentina's 2004 and Brazil's 2017 national laws, which signaled advancements in the areas of health care and human rights through the creation of numerous obstacles for migrants. For migrants living in Latin American countries during the COVID 19 Epidemic, food insecurity and unemployment occurred. More than 5.5 million migrants arrived in this region from Latin America Countries (LACs), 4.6 million of whom presently reside in the Latin America region. This comprehensive review has covered infectious diseases connected to migration in Latin America, particularly during the prevalence of chronic infections, the epidemiological pattern occurring in various regions of Latin America, and health implications during the COVID-19 pandemic and beyond.

​​Keywords: Turning, Cutting speed, Feed, Cutting temperature, A286 superalloy, Minimum quantity lubrication, Nanofluids.

​References

  1. Bourbeau P, ed. Handbook on migration and security. Cheltenham, UK Northampton, MA, USA: Edward Elgar Publishing; 2017. p.429.
  2. Shultz JM, Rechkemmer A, Rai A, et al. Public Health and Mental Health Implications of Environmentally Induced Forced Migration. Disaster Med Public Health Prep. 2019;13(2):116–122.
  3. Dyck M, Wenner J, Wengler A, et al. [Migration and health in Germany-available data sources]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019;62(8):935–942.
  4. Razum O, Wenner J. Social and health epidemiology of immigrants in Germany: past, present and future. Public Health Rev. 2016;37:4.
  5. Rechel B, Mladovsky P, Ingleby D, et al. Migration and health in an increasingly diverse Europe. The Lancet. 2013;381(9873):1235–1245.
  6. Ikram UZ, Mackenbach JP, Harding S, et al. All-cause and cause-specific mortality of different migrant populations in Europe. Eur J Epidemiol. 2016;31(7):655–665.
  7. Gallo Marin B, Amaya A, Medina Perez G, et al. A scoping review of non-communicable diseases and maternal and child health needs of Venezuelan migrants in South America. Journal of Global Health Reports [electronic article]. 2021;5. (https://www.joghr.org/article/23621-a-scoping-review-of-non-communicable-diseases-and-maternal-and-child-health-needs-of-venezuelan-migrants-in-south-america). (Accessed March 11, 2023)
  8. Castelli F, Sulis G. Migration and infectious diseases. Clinical Microbiology and Infection. 2017;23(5):283–289.
  9. Wickramage K, Siriwardhana C. Mental health of migrants in low-skilled work and the families they leave behind. The Lancet Psychiatry. 2016;3(3):194–195.
  10. Cabieses B, Tunstall H, Pickett KE, et al. Changing patterns of migration in Latin America: how can research develop intelligence for public health? Rev Panam Salud Publica. 2013;34(1):68–74.
  11. Ventura D, Martins da Silva J, Calderón L, et al. Migration, Migrants, and Health in Latin America and the Caribbean. In: Oxford Research Encyclopedia of Global Public Health. Oxford University Press; 2021 (Accessed February 13, 2023)
  12. Zimmerman C, Kiss L, Hossain M. Migration and Health: A Framework for 21st Century Policy-Making. PLoS Med. 2011;8(5):e1001034.
  13. Nhengu D. Covid-19 and female migrants: policy challenges and multiple vulnerabilities. CMS. 2022;10(1):23.
  14. Wickramage K, Vearey J, Zwi AB, et al. Migration and health: a global public health research priority. BMC Public Health. 2018;18(1):987.
  15. Daryanani S. When populism takes over the delivery of health care: Venezuela. ecancer [electronic article]. 2017;11. (http://www.ecancer.org/journal/editorial/73-when-populism-takes-over-the-delivery-of-health-care-venezuela.php). (Accessed February 20, 2023)
  16. The Lancet. Venezuelans’ right to health crumbles amid political crisis. The Lancet. 2019;393(10177):1177.
  17. Moonen CPB, den Heijer CDJ, Dukers-Muijrers NHTM, et al. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region. Front Public Health. 2023;11:1118227.
  18. White, Jr., AC, Atmar RL. Infections in Hispanic Immigrants. CLIN INFECT DIS. 2002;34(12):1627–1632.
  19. Crepet A, Repetto E, Al Rousan A, et al. Lessons learnt from TB screening in closed immigration centres in Italy. Int. Health. 2016;8(5):324–329.
  20. Blukacz A, Cabieses B, Mezones-Holguín E, et al. Healthcare and social needs of international migrants during the COVID-19 pandemic in Latin America: analysis of the Chilean case. Glob Health Promot. 2022;29(3):119–128.
  21. Burki T. COVID-19 in Latin America. The Lancet Infectious Diseases. 2020;20(5):547–548.
  22. Horton R. Offline: COVID-19 is not a pandemic. The Lancet. 2020;396(10255):874.
  23. Espinel Z, Chaskel R, Berg RC, et al. Venezuelan migrants in Colombia: COVID-19 and mental health. The Lancet Psychiatry. 2020;7(8):653–655.
  24. Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375(9728):1814–1829.
  25. Lopez M. Medicina, Política y Bien Común: 40 años de Historia del Programa de Control de la Tuberculosis (1973−2013). ARS med [electronic article]. 2016;40(1). (http://www.arsmedica.cl/index.php/MED/article/view/50). (Accessed February 22, 2023)
  26. World Health Organization. Global tuberculosis report 2018. Geneva: World Health Organization; 2018 (Accessed February 22, 2023.
  27. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol. 2002;155(6):565–571.
  28. Matteelli A, Rendon A, Tiberi S, et al. Tuberculosis elimination: where are we now? Eur Respir Rev. 2018;27(148):180035.
  29. Rendon A, Fuentes Z, Torres-Duque CA, et al. Roadmap for tuberculosis elimination in Latin American and Caribbean countries: a strategic alliance. Eur Respir J. 2016;48(5):1282–1287.
  30. Ranzani OT, Pescarini JM, Martinez L, et al. Increasing tuberculosis burden in Latin America: an alarming trend for global control efforts. BMJ Glob Health. 2021;6(3):e005639.
  31. Pelly T, Moore DAJ, Gilman R, et al. Recent tuberculosis advances in Latin America. Curr Opin Infect Dis. 2004;17(5):397–403.
  32. Brites D, Gagneux S. Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol Rev. 2015;264(1):6–24.
  33. Mackowiak PA, Blos VT, Aguilar M, et al. On the Origin of American Tuberculosis. Clinical Infectious Diseases. 2005;41(4):515–518.
  34. Brynildsrud OB, Pepperell CS, Suffys P, et al. Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation. Sci Adv. 2018;4(10):eaat5869.
  35. Jurberg C. Chagas: one hundred years later. Bull World Health Organ. 2009;87(7):491–492.
  36. Weltgesundheitsorganisation, ed. Control of chagas disease: second report of the WHO Expert Committee. Geneva: WHO; 2002 109 p.
  37. Antinori S, Galimberti L, Bianco R, et al. Chagas disease in Europe: A review for the internist in the globalized world. European Journal of Internal Medicine. 2017;43:6–15.
  38. World Health Organization. World malaria report 2017. Geneva: World Health Organization; 2017 (Accessed March 2, 2023).
  39. Alonso P, Noor AM. The global fight against malaria is at crossroads. The Lancet. 2017;390(10112):2532–2534.
  40. Braz RM, Duarte EC, Tauil PL. [Characteristics of malaria epidemics in the municipalities of the Brazilian Amazon, 2010]. Cad Saude Publica. 2013;29(5):935–944.
  41. Siqueira AM, Mesones-Lapouble O, Marchesini P, et al. Plasmodium vivax Landscape in Brazil: Scenario and Challenges. Am J Trop Med Hyg. 2016;95(6 Suppl):87–96.
  42. Rodríguez JCP, Uribe GÁ, Araújo RM, et al. Epidemiology and control of malaria in Colombia. Mem. Inst. Oswaldo Cruz. 2011;106(suppl 1):114–122.
  43. Carmona-Fonseca J, Olivera MJ, Yasnot-Acosta MF. A Retrospective Review on Severe Malaria in Colombia, 2007-2020. Pathogens. 2022;11(8):893.
  44. Ruiz D, Cerón V, Molina AM, et al. Implementation of malaria dynamic models in municipality level early warning systems in Colombia. Part I: description of study sites. Am J Trop Med Hyg. 2014;91(1):27–38.
  45. Rosas-Aguirre A, Gamboa D, Manrique P, et al. Epidemiology of Plasmodium vivax Malaria in Peru. Am J Trop Med Hyg. 2016;95(6 Suppl):133–144.
  46. Hotez PJ. Ten failings in global neglected tropical diseases control. PLoS Negl Trop Dis. 2017;11(12):e0005896.
  47. Local Burden of Disease HIV Collaborators. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems. BMC Med. 2021;19(1):4.
  48. Fleiz C, Arredondo J, Chavez A, et al. Fentanyl is used in Mexico’s northern border: current challenges for drug health policies. Addiction. 2020;115(4):778–781.
  49. World Health Organization. The immunological basis for immunization series: module 18: hepatitis A. 2011;(https://apps.who.int/iris/handle/10665/44570). (Accessed March 12, 2023)
  50. Jacobsen KH. Globalization and the Changing Epidemiology of Hepatitis A Virus. Cold Spring Harb Perspect Med. 2018;8(10):a031716.
  51. Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18 Suppl 1:S71-74.
  52. Rein DB, Stevens GA, Theaker J, et al. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012;55(4):988–997.
  53. Silva GR da CE, Martins TLS, Silva C de A, et al. Hepatitis A and E among immigrants and refugees in Central Brazil. Rev Saude Publica. 2022;56:29.
  54. Zhang W, Wu Y, Wen B, et al. Non-pharmaceutical interventions for COVID-19 reduced the incidence of infectious diseases: a controlled interrupted time-series study. Infect Dis Poverty. 2023;12(1):15.
  55. Spinelli MA, Glidden DV, Gennatas ED, et al. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. Lancet Infect Dis. 2021;21(9):e296–e301.
  56. Leffler CT, Ing E, Lykins JD, et al. Association of Country-wide Coronavirus Mortality with Demographics, Testing, Lockdowns, and Public Wearing of Masks. Am J Trop Med Hyg. 2020;103(6):2400–2411.
  57. Knaul F, Arreola-Ornelas H, Porteny T, et al. Not far enough: Public health policies to combat COVID-19 in Mexico’s states. PLoS One. 2021;16(6):e0251722.
  58. Pana TA, Bhattacharya S, Gamble DT, et al. Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study. BMJ Open. 2021;11(2):e042034.